Page last updated: 2024-08-25

rosiglitazone and Lymphoma

rosiglitazone has been researched along with Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dai, XJ; Fang, ZG; Huang, HQ; Huang, RW; Lin, DJ; Liu, JJ; Liu, PQ; Liu, XD; Xiao, RZ; Xu, Y; Zhang, Y	1

Other Studies

1 other study(ies) available for rosiglitazone and Lymphoma

Article	Year
Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-γ ligands via Wnt signaling pathway. Cell biochemistry and biophysics, 2012, Volume: 62, Issue:1 Topics: Anilides; Antineoplastic Agents; Apoptosis; beta Catenin; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Ligands; Lymphoma; Phosphorylation; PPAR gamma; Rosiglitazone; Thiazolidinediones; Wnt Signaling Pathway	2012

Article

Year

Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-γ ligands via Wnt signaling pathway.

Cell biochemistry and biophysics, 2012, Volume: 62, Issue:1

Topics: Anilides; Antineoplastic Agents; Apoptosis; beta Catenin; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Ligands; Lymphoma; Phosphorylation; PPAR gamma; Rosiglitazone; Thiazolidinediones; Wnt Signaling Pathway

2012